Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

JK Hicks, JJ Swen, CF Thorn… - Clinical …, 2013 - Wiley Online Library
Polymorphisms in CYP2D6 and CYP2C19 affect the efficacy and safety of tricyclics, with
some drugs being affected by CYP2D6 only, and others by both polymorphic enzymes …
被引用次数：519 相关文章

[引用][C] Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

JK Hicks, JJ Swen, CF Thorn… - Clinical …, 2013 - scholarlypublications …
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19
Genotypes and Dosing of Tricyclic Antidepressants | Scholarly Publications Skip to main …
[HTML] nih.gov

[HTML][HTML] Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

JK Hicks, JJ Swen, CF Thorn, K Sangkuhl… - Clinical …, 2013 - ncbi.nlm.nih.gov
Polymorphisms in CYP2D6 and CYP2C19 affect the efficacy and safety of tricyclics, with
some drugs being affected by CYP2D6 only, and others by both polymorphic enzymes …

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants.

JK Hicks, JJ Swen, CF Thorn… - Clinical …, 2013 - search.ebscohost.com
Polymorphisms in CYP2D6 and CYP2C19 affect the efficacy and safety of tricyclics, with
some drugs being affected by CYP2D6 only, and others by both polymorphic enzymes …

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.

JK Hicks, JJ Swen, CF Thorn, K Sangkuhl… - Clinical …, 2013 - europepmc.org
Polymorphisms in CYP2D6 and CYP2C19 affect the efficacy and safety of tricyclics, with
some drugs being affected by CYP2D6 only, and others by both polymorphic enzymes …

[引用][C] Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

JK Hicks, JJ Swen, CF Thorn, K Sangkuhl… - Clinical Pharmacology …, 2013 - cir.nii.ac.jp
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and
CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants | CiNii Research CiNii 国立 …

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants

JK Hicks, JJ Swen, CF Thorn… - Clinical …, 2013 - pubmed.ncbi.nlm.nih.gov
Polymorphisms in CYP2D6 and CYP2C19 affect the efficacy and safety of tricyclics, with
some drugs being affected by CYP2D6 only, and others by both polymorphic enzymes …

[引用][C] Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

JK HICKS, JJ SWEN, CF THORN… - Clinical …, 2013 - pascal-francis.inist.fr
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19
Genotypes and Dosing of Tricyclic Antidepressants CNRS Inist Pascal-Francis CNRS Pascal …
[PDF] researchgate.net

[PDF][PDF] Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6and CYP2C19Genotypes and Dosing of Tricyclic Antidepressants

JK Hicks, JJ Swen, CF Thorn, K Sangkuhl… - CLiniCAL …, 2013 - researchgate.net
CPIC GuIdelInes alleles are categorized into functional groups as follows: functional (eg,
CYP2D6* 1and* 2), reduced function (eg, CYP2D6* 9,* 10, and* 41), and nonfunctional (eg …
[PDF] umich.edu

[PDF][PDF] Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

JK Hicks, JJ Swen, CF Thorn, K Sangkuhl… - 2013 - deepblue.lib.umich.edu
CPIC GuIdelInes alleles are categorized into functional groups as follows: functional (eg,
CYP2D6* 1and* 2), reduced function (eg, CYP2D6* 9,* 10, and* 41), and nonfunctional (eg …